ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,985.38
      0.02%
      US Tech 100
      20,488.00
      -0.14%
      Dow Jones
      43,958.19
      0.11%
      Brent Oil
      71.865
      0.34%
      Bitcoin
      90,534.03
      2.97%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Processa Pharmaceuticals Inc (PCSA)

      7. Processa Pharmaceuticals Inc (PCSA) Financials

      Processa Pharmaceuticals Inc

      Processa Pharmaceuticals Inc (PCSA)

      NASDAQ
      1.07
      0.00
      (0.00%)
      At close: November 13 4:00PM
      Delayed by 15 minutes
      1.07
      0.00
      ( 0.00% )
      After Hours: 4:42PM
      Delayed by 15 minutes

      Processa Pharmaceuticals Inc Financial Summary

      The current PCSA market cap is 3.5M. The company's latest EPS is USD -3.4044 and P/E is -0.31.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -2.17M-2.47M-2.81M-3.08M-3.42M
      Net Income -2.08M-2.41M-2.73M-3.01M-3.38M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -3.94M-15.14M-12.13M-27.53M-11.46M
      Net Income -3.36M-14.41M-11.43M-27.42M-11.12M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 8.08M5.79M9.95M7.6M4.94M
      Total Liabilities 915k798k1.06M1.58M1.22M
      Total Equity 7.17M4.99M8.88M6.02M3.72M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 10.88M25.21M26.46M8.62M5.79M
      Total Liabilities 2.87M2.28M979k1.15M798k
      Total Equity 8.01M22.94M25.49M7.47M4.99M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -5.94M-8.06M-2.05M-5.4M-9M
      Investing -3k-3k N/A N/A -3k
      Financing 6.3M6.27M6.26M6.26M7.19M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -2.75M-3.14M-8.72M-9.61M-8.06M
      Investing N/A N/A N/A N/A -3k
      Financing 1.7M17.87M9.8M-389k6.27M

      Stats and Ratios

      Market Cap 3.5M
      Price to Earnings Ratio -0.31
      Price to Sales Ratio 0
      Price to Cash Ratio 0.74
      Price to Book Ratio 0.7
      Dividend Yield -

      Share Statistics

      Shares Outstanding 3.27M
      Average Volume (1 week) 19.91k
      Average Volume (1 Month) 27.95k
      52 Week Change -82.62%
      52 Week High 17.40
      52 Week Low 1.05
      Spread (Intraday) 0.06 (5.26%)

      Company Info

      Company Name Processa Pharmaceuticals Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://
      Industry pharmaceutical preparations (2834)